Cargando…
SH2B1 promotes epithelial‐mesenchymal transition through the IRS1/β‐catenin signaling axis in lung adenocarcinoma
Lung adenocarcinoma (LADC), the most prevalent type of human lung cancer, is characterized by many molecular abnormalities. SH2B1, a member of the SH2‐domain containing family, have recently been shown to act as tumor activators in multiple cancers, including LADC. However, the mechanisms underlying...
Autores principales: | Wang, Shaoqiang, Cheng, Yuanda, Gao, Yang, He, Zhiwei, Zhou, Wolong, Chang, Ruimin, Peng, Zhenzi, Zheng, Yingying, Duan, Chaojun, Zhang, Chunfang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5900930/ https://www.ncbi.nlm.nih.gov/pubmed/29380446 http://dx.doi.org/10.1002/mc.22788 |
Ejemplares similares
-
PRKAR1A is a functional tumor suppressor inhibiting ERK/Snail/E-cadherin pathway in lung adenocarcinoma
por: Wang, Shaoqiang, et al.
Publicado: (2016) -
SH2B1 promotes NSCLC cell proliferation through PI3K/Akt/mTOR signaling cascade
por: Wang, Shaoqiang, et al.
Publicado: (2018) -
MicroRNA-361-3p suppresses tumor cell proliferation and metastasis by directly targeting SH2B1 in NSCLC
por: Chen, Wei, et al.
Publicado: (2016) -
MicroRNA‐331‐3p inhibits epithelial‐mesenchymal transition by targeting ErbB2 and VAV2 through the Rac1/PAK1/β‐catenin axis in non‐small‐cell lung cancer
por: Li, Xizhe, et al.
Publicado: (2019) -
Prognostic significance of tumor-associated macrophages polarization markers in lung cancer: a pooled analysis of 5105 patients
por: Yi, Bin, et al.
Publicado: (2023)